Quintiles

Survey: Biopharmaceutical industry needs innovation

Tuesday, July 12, 2011 12:12 PM

A new Economist Intelligence Unit survey sponsored by CRO Quintiles highlights the urgent need for biopharmaceutical industry innovation. The global survey comes as the biopharma sector reaches the patent cliff—this year and next, seven of the world’s 15 top-selling drugs, accounting for nearly $50 billion in sales in 2009, will go off-patent.

More... »

Quintiles invests $1 million in Prana Biotechnology

Tuesday, July 5, 2011 12:21 PM

Quintiles is raising its stake in Prana Biotechnology, an Australian company focused on Alzheimer’s disease and other major age-related neurodegenerative disorders, by acquiring $1 million worth of new Prana shares, according to PharmaTimes.

More... »

Quintiles invests in Swiss biotech Kareus

Tuesday, June 14, 2011 01:54 PM

In further evidence of a shift toward more fundamental risk-sharing in drug development between biopharmaceutical companies and CROs, Quintiles is making a significant investment in Swiss biotech Kareus Therapeutics as part of a broad strategic alliance to move two of Kareus’ pre-clinical programs through clinical trials, according to PharmaTimes.

More... »

Quintiles’ Chasse, Sanofi Pasteur’s Milam make unprecedented industry move to the site world

Monday, May 23, 2011 08:44 AM

Christine Pierre, president of the investigator site group and consultancy RxTrials, shocked parts of the industry this month when she hired Adam Chasse away from global CRO Quintiles and Dan Milam from Sanofi Pasteur, the largest company in the world devoted to vaccines.

More... »

Quintiles collaborates with PGT

Tuesday, May 17, 2011 11:32 AM

Quintiles has partnered with Population Genetics Technologies (PGT), a U.K.-based company that specializes in large-scale, lower-cost genomic analyses, according to PharmaTimes.

More... »

RxTrials hires Adam Chasse as vice president of business development

Wednesday, May 11, 2011 10:17 AM

RxTrials president, Christine Pierre, has named Adam Chasse vice president of business development. Chasse, who has been head of prime sites for Quintiles, will begin immediately and be based in Triangle Park, N.C.

More... »

Quintiles adds two Prime Sites in effort to expand its global alliance program to 20 sites by year-end

Monday, May 9, 2011 09:40 AM

CRO Quintiles will soon announce the addition of two new sites to its elite Prime Sites program. Both in the U.K., they are: University Hospitals Birmingham NHS Foundation Trust; and the Royal Devon and Exeter Foundation Trust, with its academic arm Peninsula College of Medicine and Dentistry and the Royal Cornwall Hospital.

More... »

Beardsworth strengthens oncology operations

Thursday, May 5, 2011 01:08 PM

CRO Beardsworth has promoted Evette Riegel, RN, to senior director, clinical operations and project management and has added Saishree Ramalingam, MS, MPhil, as senior project manager.

More... »

Thomas Littlejohn will be remembered for his innovation, spirit and desire to give back

Monday, April 11, 2011 03:07 AM

It’s the laughter that the staff of site group PMG Research say they will miss the most about Thomas W. Littlejohn III. His was a baritone laugh that could often be heard booming down the hallway at any of PMG’s 11 sites, usually accompanied by knee slapping and, if you were in the room with him, a jolly red face.

More... »

Quintiles named a preferred provider for global PDPs

Tuesday, March 29, 2011 12:18 PM

Quintiles has been named a preferred provider to a consortium of 14 global health product development partnerships (PDPs), leveraging the combined size of their pipelines to ensure the most cost-effective use of their research and development dollars.

More... »